CHICAGO -- What role should ezetimibe (Zetia), niacin, and other nonstatin strategies play in managing LDL cholesterol? A new consensus document from the American College of Cardiology recommends a pathway for making the decision with patients.
Discussing the document in this video are:
- Christie M. Ballantyne, MD, of Baylor College of Medicine in Houston
- Charlie Hennekens, MD, DrPH, of Florida Atlantic University in Boca Raton
- Jennifer Robinson, MD, MPH, of the University of Iowa in Iowa City
- Neil Stone, MD, of Northwestern Memorial Hospital in Chicago
- Howard Weintraub, MD, of NYU-Langone Medical Center in New York City
The document was published in the Journal of the American College of Cardiology and presented here at the organization's conference.
Aucun commentaire:
Enregistrer un commentaire